Citation: | SHEN X J, LU Y H, LIANG Z H. Diagnosis of Pleomorphic Xanthoastrocytoma with Enhanced MRI Examination: A Clinical Case Analysis[J]. CT Theory and Applications, xxxx, x(x): 1-5. DOI: 10.15953/j.ctta.2024.090. (in Chinese). |
Pleomorphic xanthoastrocytoma (PXA) is a primary central nervous system tumor characterized primarily by epileptic seizures as its clinical manifestation. Due to overlapping clinical and radiological findings with other intracranial tumors, and its rarity in clinical settings, PXA is easily misdiagnosed. Here, we report a case of PXA in a 16-year-old male who experienced a sudden epileptic seizure. Cranial magnetic resonance imaging (MRI) showed a cystic-solid lesion in the left temporal lobe, which was interpreted as a possible glioma. The patient underwent a gross total resection of the tumor, and the pathological examination confirmed the diagnosis of PXA (World Health Organization grade 2). After the previous treatment, the patient did not experience any epileptic seizures. During a follow-up period of approximately 1 year, a cranial MRI indicated no signs of tumor recurrence. In this report, a comprehensive literature review based on the imaging findings in this case was conducted to summarize the imaging features of PXA, aiming to enhance the clinicians’ understanding and provide guidance for accurate diagnosis.
[1] |
KEPES J J, RUBINSTEIN L J, ENG L F. Pleomorphic xanthoastrocytoma: A distinctive meningocerebral glioma of young subjects with relatively favorable prognosis. A study of 12 cases[J]. Cancer, 1979, 44(5): 1839−1852. DOI:10.1002/1097-0142(197911)44:5<1839::aid-cncr2820440543>3.0.co;2-0.
|
[2] |
KEPES J J, KEPES M, SLOWIK F. Fibrous xanthomas and xanthosarcomas of the meninges and the brain[J]. Acta Neuropathol, 1973, 23(3): 187−199. DOI: 10.1007/BF00687875.
|
[3] |
MISTRY M, ZHUKOVA N, MERICO D, et al. BRAF mutation and CDKN2A deletion define a clinically distinct subgroup of childhood secondary high-grade glioma[J]. Journal of Clinical Oncology, 2015, 33(9): 1015−1022. DOI: 10.1200/JCO.2014.58.3922.
|
[4] |
VAUBEL R A, CARON A A, YAMADA S, et al. Recurrent copy number alterations in low-grade and anaplastic pleomorphic xanthoastrocytoma with and without BRAF V600E mutation[J]. Brain Pathology, 2018, 28(2): 172−182. DOI: 10.1111/bpa.12495.
|
[5] |
PERKINS S M, MITRA N, FEI W, et al. Patterns of care and outcomes of patients with pleomorphic xanthoastrocytoma: A SEER analysis[J]. Journal of Neuro-oncology, 2012, 110(1): 99−104. DOI: 10.1007/s11060-012-0939-8.
|
[6] |
OSTROM Q T, PRICE M, NEFF C, et al. CBTRUS statistical report: Primary brain and other central nervous system tumors diagnosed in the united states in 2015-2019[J]. Neuro-oncology, 2022, 24(S5): v1−v95. DOI: 10.1093/neuonc/noac20216.
|
[7] |
IDA C M, RODRIGUEZ F J, BURGER P C, et al. Pleomorphic Xanthoastrocytoma: Natural History and Long-Term Follow-Up[J]. Brain Pathology, 2015, 25(5): 575−586. DOI: 10.1111/bpa.12217.
|
[8] |
VAUBEL R, ZSCHERNACK V, TRAN Q T, et al. Biology and grading of pleomorphic xanthoastrocytoma-what have we learned about it?[J]. Brain Pathology, 2021, 31(1): 20−32. DOI: 10.1111/bpa.12874.
|
[9] |
DONO A, LOPEZ-RIVERA V, CHANDRA A, et al. Predictors of outcome in pleomorphic xanthoastrocytoma[J]. Neuro-oncology Practice, 2021, 8(2): 222−229. DOI: 10.1093/nop/npaa076.
|
[10] |
秦汉, 胡军民, 元玲, 等. 多形性黄色瘤型星形细胞瘤的诊治分析: 附7例报道并文献复习[J]. 中国临床神经外科杂志, 2019, 24(12): 721−723. DOI: 10.13798/j.issn.1009-153X.2019.12.001.
|
[11] |
JOHNSON D R, GIANNINI C, JENKINS R B, et al. Plenty of calcification: Imaging characterization of polymorphous low-grade neuroepithelial tumor of the young[J]. Neuroradiology, 2019, 61(11): 1327−1332. DOI: 10.1007/s00234-019-02269-y.
|
[1] | ZHAO Huali, LIANG Zonghui. The Diagnosis of Acinar Cell Soft Tissue Sarcoma with Enhanced Computed Tomography and Magnetic Resonance Imaging Examination: A Clinical Case Analysis[J]. CT Theory and Applications, 2024, 33(4): 524-530. DOI: 10.15953/j.ctta.2023.207 |
[2] | SHI Donghui, FENG Feng. MRI Diagnosis of Ovarian Malignant Germ Cell Tumors[J]. CT Theory and Applications, 2019, 28(1): 129-137. DOI: 10.15953/j.1004-4140.2019.28.01.14 |
[3] | FU Ai-yan, DUAN Shu-feng, JI Lei-yan, FENG Feng. Diagnostic Value of High Resolution MRI on Mesenteric Lymph Node Metastasis of Rectal Cancer[J]. CT Theory and Applications, 2018, 27(4): 519-528. DOI: 10.15953/j.1004-4140.2018.27.04.13 |
[4] | WU Yan-chun, LIU Yao. Clinical Value of CT、MRI in the Diagnosis of Cystic Lesions of the Pancreas and the Pathological Analysis[J]. CT Theory and Applications, 2017, 26(5): 591-597. DOI: 10.15953/j.1004-4140.2017.26.05.08 |
[5] | WU Hui-qin, QIAN Chun-mei. The Application of MRI in the Diagnosis of Cervical Cancer[J]. CT Theory and Applications, 2015, 24(4): 581-586. DOI: 10.15953/j.1004-4140.2015.24.04.12 |
[6] | LI Xiao-qiang, JIN Er-hu, ZHANG Bin-bin, ZHENG Xin. Study of CT and MRI Diagnosis for the Pancreatic Lipomas[J]. CT Theory and Applications, 2014, 23(4): 601-610. |
[7] | LIU Jin-cai, CHEN Hua-ping. Analysis MRI of Hemangioblastoma[J]. CT Theory and Applications, 2007, 16(4): 61-65. |
[8] | LÜ Guo-shi, XU Yi-kai. Lateral Ventricular Ependymomas: MR Imaging Features and Differential Diagnosis[J]. CT Theory and Applications, 2007, 16(4): 51-55. |
[9] | XU Peng-jun, XU Yi-kai, DAI Lin. MRI Diagnosis of Cerebella Astrocytoma[J]. CT Theory and Applications, 2005, 14(4): 29-32. |
[10] | QI Rong-xiu, FANG Ting-song, XU Yi-kai. Diagnosis of Giant Cell Tumor of Bone with CT,MRI[J]. CT Theory and Applications, 2004, 13(1): 10-14. |